The estimated Net Worth of Lawrence A. Siebert is at least 564 千$ dollars as of 8 November 2013. Lawrence Siebert owns over 30,000 units of Chembio Diagnostics stock worth over 363,175$ and over the last 20 years Lawrence sold CEMI stock worth over 200,424$.
Lawrence has made over 9 trades of the Chembio Diagnostics stock since 2008, according to the Form 4 filled with the SEC. Most recently Lawrence sold 30,000 units of CEMI stock worth 108,900$ on 8 November 2013.
The largest trade Lawrence's ever made was buying 1,000,800 units of Chembio Diagnostics stock on 15 May 2008 worth over 100,080$. On average, Lawrence trades about 39,122 units every 57 days since 2004. As of 8 November 2013 Lawrence still owns at least 789,510 units of Chembio Diagnostics stock.
You can see the complete history of Lawrence Siebert stock trades at the bottom of the page.
Lawrence's mailing address filed with the SEC is 3661 HORSEBLOCK ROAD, , MEDFORD, NY, 11763.
Over the last 20 years, insiders at Chembio Diagnostics have traded over 909,824$ worth of Chembio Diagnostics stock and bought 3,754,893 units worth 1,696,058$ . The most active insiders traders include Credit Advisors, Llcpercept...、Lawrence A. Siebert、Richard Eberly. On average, Chembio Diagnostics executives and independent directors trade stock every 90 days with the average trade being worth of 36,203$. The most recent stock trade was executed by Credit Advisors, Llcpercept... on 21 April 2023, trading 243,448 units of CEMI stock currently worth 109,552$.
Chembio is a leading point-of-care diagnostics company focused on detecting and diagnosing infectious diseases, including COVID-19, sexually transmitted disease, and fever and tropical disease. Coupled with Chembio's extensive scientific expertise, its novel DPP technology offers broad market applications beyond infectious disease. Chembio's products are sold globally, directly and through distributors, to hospitals and clinics, physician offices, clinical laboratories, public health organizations, government agencies, and consumers.
Chembio Diagnostics executives and other stock owners filed with the SEC include: